Sign Up Today and Learn More About Volastra Therapeutics Stock
Invest in or calculate the value of your shares in Volastra Therapeutics or other pre-IPO companies through EquityZen's platform.
Volastra Therapeutics Stock (VOTH)
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
About Volastra Therapeutics Stock
Founded
2019
Headquarters
New York, NY, US
Industries
Software, Artificial Intelligence, Data and Analytics
Volastra Therapeutics Press Mentions
Stay in the know about the latest news on Volastra Therapeutics
Aryl indol-3-yl ketone and aryl indazol-3-yl ketone inhibitors of kif18a
patents • Apr 02, 2025
Method of treating cancer with indoline inhibitors of kif18a
patents • Apr 02, 2025
COMPOUNDS TO INHIBIT KIF18A
patents • Apr 02, 2025
Heterocyclic inhibitors of enpp1
patents • Feb 08, 2025
Indoline compounds for inhibiting kif18a
patents • Feb 08, 2025
Volastra Therapeutics Management
Leadership team at Volastra Therapeutics
Chief Scientific Officer
Michael Su
Co-Founder
Samuel Bakhoum
Join now and verify your accreditation status to gain access to:
- Volastra Therapeutics Current Valuation
- Volastra Therapeutics Stock Price
- Volastra Therapeutics Management
- Available deals in Volastra Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Volastra Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Volastra Therapeutics Revenue and Financials
- Volastra Therapeutics Highlights
- Volastra Therapeutics Business Model
- Volastra Therapeutics Risk Factors
- Volastra Therapeutics Research Report from SACRA Research
Trading Volastra Therapeutics Stock
How to invest in Volastra Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Volastra Therapeutics through EquityZen funds. These investments are made available by existing Volastra Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Volastra Therapeutics stock?
Shareholders can sell their Volastra Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
